IMNM
Immunome, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -12.5% ·
aandelenstroom -5.5% ·
netto nieuwe posities -14.3%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | 0 | 68.26M | $1.45B | +7 | −7 |
| Q1 2026 | 85 | +8 | 69.87M | $1.52B | +12 | −4 |
| Q4 2025 | 77 | -1 | 71.18M | $1.53B | — | −1 |
| Q3 2025 | 17 | 0 | 44.21M | $517.66M | +1 | −1 |
| Q2 2025 | 14 | -2 | 33.29M | $309.62M | — | −2 |
| Q1 2025 | 13 | 0 | 18.78M | $126.42M | +1 | −1 |
| Q4 2024 | 13 | +3 | 9.20M | $97.76M | +3 | — |
| Q3 2024 | 9 | -2 | 5.86M | $85.63M | — | −2 |
| Q2 2024 | 11 | — | 5.95M | $72.02M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 6.17M | — | $57.36M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 6.17M | — | $57.36M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 5.77M | — | $53.67M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 5.77M | — | $53.67M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 5.77M | — | $53.67M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 5.77M | — | $53.67M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 5.77M | — | $53.67M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 5.77M | — | $53.67M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 5.77M | — | $53.67M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 5.77M | — | $53.67M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 5.77M | — | $53.67M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 5.77M | — | $53.67M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 4.69M | +7.5% | $43.58M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 4.52M | — | $42.08M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 4.52M | — | $42.08M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 4.52M | — | $42.08M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 4.52M | — | $42.08M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 4.52M | — | $42.08M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | PRIMECAP Management ✦ | 3.02M | -11.5% | $28.09M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 2.98M | -2.9% | $27.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 2.98M | -2.9% | $27.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | State Street Global Advisors ✦ (passief) | 2.52M | -4.5% | $23.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passief) | 1.86M | +6.7% | $17.31M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passief) | 1.86M | +6.7% | $17.31M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Marshall Wace ✦ | 1.30M | -19.4% | $12.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Marshall Wace ✦ | 1.30M | -19.4% | $12.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | Wellington Management ✦ | 211.83K | +38.4% | $1.97M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 211.83K | +38.4% | $1.97M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 211.83K | +38.4% | $1.97M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Millennium Management ✦ | 113.55K | -75.4% | $1.06M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 31 | Renaissance Technologies ✦ | 99.37K | -14.3% | $924,160 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | Two Sigma Investments ✦ | 26.65K | -70.3% | $247,882 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 33 | Gotham Asset Management ✦ | 10.20K | 0.0% | $94,860 | 0.0% | Held | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Adage Capital Partners | $5.22M | was 0.0% |
| Citadel Advisors | $2.29M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 35.50K aandelen, $776 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 11.05K aand · $301,058
Director · 62.29K aand · $1.63M
Director · 10.12K aand · $263,959
Director · 15.25K aand · $397,363
Director · 20.84K aand · $543,090
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie